A Fight to Save Kids and Change Science

Monday, November 25, 2013

Wall Street Journal reporter Amy Dockser Marcus discusses her investigative health piece, “Trials.” For six years, The Wall Street Journal followed a group of parents and scientists seeking a treatment for a rare and fatal genetic disease (Niemann-Pick Type C) that strikes primarily children. Their collaboration accelerated development of a promising drug and, along the way, pushed the boundaries of medical science itself.


Amy Dockser Marcus
News, weather, Radiolab, Brian Lehrer and more.
Get the best of WNYC in your inbox, every morning.

Comments [3]

Truth & Beauty from Brooklyn

@ thatgirl from manhattan: That may be so, but Ms. Marcus didn't even mention them. I googled this condition when they started their discussion and it said it is because of aggregate cholesterol in various organs and statins are the first thing that came to mind, but didn't make it into the discussion.

@ Independent_Noach: What the H**L are you talking about?!? How is that even remotely related to this discussion?

Nov. 25 2013 02:17 PM
thatgirl from manhattan

Statins aren't right for everyone--in fact, they're right for fewer people than pharma would have you believe.

Nov. 25 2013 01:12 PM
Truth & Beauty from Brooklyn

If it's a problem with cholesterol, why don't they treat them with statins?

Nov. 25 2013 12:25 PM

Leave a Comment

Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.